Lexaria Bioscience formulates enhanced DehydraTECH for more efficient cannabis delivery

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) CEO Chris Bunka tells Proactive Investors a new version of the Kelowna, British Columbia company’s DehydraTECH delivery platform has been developed.

Bunka says this new version provides significant improvements geared for use in solid oral dosage forms like capsules, tablets and pills for the pharmaceutical and supplement markets, as well as for cannabis.


%d bloggers like this: